30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Paolo Pucci

Insider profile

Currently holds positions in ArQule Inc, West Pharmaceutical Services Inc and Replimune Group Inc

Performance

Overall performance
3.8

Performance over holding periods
3.8
30 days 90 days 120 days
Average return 5% 8.2% 15.1%
Success rate 93% 68% 82%
Transactions
10 100% Buy
34 71% Buy
47 69% Buy

Positions

Position Company Period
Chief Executive Officer ArQule Inc Jan. 16, 2020 -
Director West Pharmaceutical Services Inc Sept. 12, 2016 -
Director Replimune Group Inc April 2, 2020 -
Chief Executive Officer, Director ArQule Inc June 9, 2008 - Jan. 16, 2020
Director Lumos Pharma Inc Nov. 12, 2015 - Oct. 31, 2018
Independent Director Dyax Corp Nov. 1, 2011 - Jan. 22, 2016

Paolo Pucci's trades of Imperial Brands PLC's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2024-10-08 2024-10-03 B Purchase
9,989
331.89
£1,790,548
9,989 331.89 £1,790,548
2024-07-10 2024-07-03 B Purchase
65,652
50.38
£1,925,611
65,652 50.38 £1,925,611
2024-04-10 2024-04-04 B Purchase
79,155
347.85
£1,727,413
79,155 347.85 £1,727,413
2024-01-08 2024-01-04 B Purchase
426
18.58
£7,906
426 18.58 £7,906
2023-10-09 2023-10-04 B Purchase
194
16.21
£3,151
194 16.21 £3,151
2023-07-07 2023-07-05 B Purchase
175
17.87
£3,135
175 17.87 £3,135
2023-04-11 2023-04-05 B Purchase
224
18.80
£4,205
224 18.80 £4,205
2023-01-10 2023-01-05 B Purchase
196
20.91
£4,108
196 20.91 £4,108
2022-10-10 2022-10-05 B Purchase
93
18.93
£1,752
93 18.93 £1,752
2022-07-07 2022-07-05 B Purchase
96
18.07
£1,732
96 18.07 £1,732